Skip to main content
Premium Trial:

Request an Annual Quote

Biotrove Closes $7M in VC Funding to Help Sell OpenArray and RapidFire Products

NEW YORK, March 8 (GenomeWeb News) - Biotrove announced today that it closed $7 million in round of private-equity funding, bringing to $15 million its total venture capital financing since July 2005.

 

The round, which was oversubscribed, will help the company sell its OpenArray and RapidFire products.

 

Investors included Catalyst Health and Technology Partners, Echelon Ventures, Fletcher Spaght, and CB Health Ventures.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.